Zhang JL - Search Results

1

Biocompatible polymeric nanocomplexes as an intracellular stimuli-sensitive prodrug for type-2 diabetes combination therapy.

Wang FZ, Xie ZS, Xing L, Zhang BF, Zhang JL, Cui PF, Qiao JB, Shi K, Cho CS, Cho MH, Xu X, Li P, Jiang HL. Wang FZ, et al. Among authors: zhang bf, zhang jl. Biomaterials. 2015 Dec;73:149-59. doi: 10.1016/j.biomaterials.2015.09.013. Epub 2015 Sep 11. Biomaterials. 2015. PMID: 26409000

2

Mitochondria apoptosis pathway synergistically activated by hierarchical targeted nanoparticles co-delivering siRNA and lonidamine.

Zhang BF, Xing L, Cui PF, Wang FZ, Xie RL, Zhang JL, Zhang M, He YJ, Lyu JY, Qiao JB, Chen BA, Jiang HL. Zhang BF, et al. Among authors: zhang m, zhang jl. Biomaterials. 2015 Aug;61:178-89. doi: 10.1016/j.biomaterials.2015.05.027. Epub 2015 May 16. Biomaterials. 2015. PMID: 26004233

3

Transferrin-inspired vehicles based on pH-responsive coordination bond to combat multidrug-resistant breast cancer.

He YJ, Xing L, Cui PF, Zhang JL, Zhu Y, Qiao JB, Lyu JY, Zhang M, Luo CQ, Zhou YX, Lu N, Jiang HL. He YJ, et al. Among authors: zhang m, zhang jl. Biomaterials. 2017 Jan;113:266-278. doi: 10.1016/j.biomaterials.2016.11.001. Epub 2016 Nov 2. Biomaterials. 2017. PMID: 27842254

4

Polyamine metabolism-based dual functional gene delivery system to synergistically inhibit the proliferation of cancer.

Cui PF, Xing L, Qiao JB, Zhang JL, He YJ, Zhang M, Lyu JY, Luo CQ, Jin L, Jiang HL. Cui PF, et al. Among authors: zhang m, zhang jl. Int J Pharm. 2016 Jun 15;506(1-2):79-86. doi: 10.1016/j.ijpharm.2016.04.039. Epub 2016 Apr 19. Int J Pharm. 2016. PMID: 27102990

5

In vivo synergistic antitumor effect and safety of siRNA and lonidamine dual-loaded hierarchical targeted nanoparticles.

Zhang BF, Xing L, Qiao JB, Cui PF, Wang FZ, Zhang JL, Xu CX, Jiang HL. Zhang BF, et al. Among authors: zhang jl. Int J Pharm. 2016 Jun 15;506(1-2):207-13. doi: 10.1016/j.ijpharm.2016.04.056. Epub 2016 Apr 22. Int J Pharm. 2016. PMID: 27113867

6

One-step assembly of polymeric demethylcantharate prodrug/Akt1 shRNA complexes for enhanced cancer therapy.

Zhang JL, Gong JH, Xing L, Cui PF, Qiao JB, He YJ, Zhang M, Lyu JY, Luo CQ, Che SA, Jin T, Jiang HL. Zhang JL, et al. Among authors: zhang m. Int J Pharm. 2016 Nov 20;513(1-2):612-627. doi: 10.1016/j.ijpharm.2016.09.070. Epub 2016 Sep 25. Int J Pharm. 2016. PMID: 27682215

7

A novel design of a polynuclear co-delivery system for safe and efficient cancer therapy.

Xing L, Zhang JL, Zhou TJ, He YJ, Cui PF, Gong JH, Sun M, Lu JJ, Huang Z, Jin L, Jiang HL. Xing L, et al. Among authors: zhang jl. Chem Commun (Camb). 2018 Aug 14;54(63):8737-8740. doi: 10.1039/c8cc03720e. Epub 2018 Jul 20. Chem Commun (Camb). 2018. PMID: 30027958

8

Folate-conjugated polyspermine for lung cancer-targeted gene therapy.

Zhang M, Kim YK, Cui P, Zhang J, Qiao J, He Y, Lyu J, Luo C, Xing L, Jiang H. Zhang M, et al. Acta Pharm Sin B. 2016 Jul;6(4):336-43. doi: 10.1016/j.apsb.2016.03.010. Epub 2016 Apr 12. Acta Pharm Sin B. 2016. PMID: 27471674 Free PMC article.

9

Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles.

Wang X, Zhen X, Wang J, Zhang J, Wu W, Jiang X. Wang X, et al. Biomaterials. 2013 Jun;34(19):4667-79. doi: 10.1016/j.biomaterials.2013.03.008. Epub 2013 Mar 26. Biomaterials. 2013. PMID: 23537667

10

Bioreducible heparin-based nanogel drug delivery system.

Wu W, Yao W, Wang X, Xie C, Zhang J, Jiang X. Wu W, et al. Biomaterials. 2015 Jan;39:260-8. doi: 10.1016/j.biomaterials.2014.11.005. Epub 2014 Nov 20. Biomaterials. 2015. PMID: 25468376

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,960 results

Search Page

Filters